Organophosphorus poisoning can occur when one is exposed to organophosphates for too long or at high levels. Organophosphates are a common type of insecticide. However, high levels of organophosphates can be harmful to humans and other animals.
Organophosphates are useful as pharmaceuticals, pesticides, and as nerve agents. Due to the extensive usage of these chemicals in agriculture, the majority of organophosphate toxicity cases presently involve farmers and other individuals who function in this field.
Organophosphate molecules can penetrate the body through the skin, by inhalation, or through the digestive system
The molecule permeates red blood cells where it binds to an acetylcholinesterase molecule, making the enzyme inactive
This causes synapses and neuromuscular junctions to accumulate an excess of acetylcholine
Myoclonic jerks and fasciculations can occur as a result of the overstimulation of nicotinic receptors at neuromuscular junctions
The depolarizing blockage ultimately results in flaccid paralysis
The adrenal glands have nicotinic receptors, which can lead to hypertension, perspiration, tachycardia, and leukocytosis with a left shift
The effects of organophosphate poisoning on muscarinic receptors result in additional symptoms
G-protein-coupled receptors are responsible for these effects, which are typically slower than those of nicotinic receptors
Organophosphate toxicity has parasympathetic effects on several systems, including the heart, exocrine glands, and smooth muscles
Symptoms range from mild to moderate depending on the exposure to organophosphates, they include:
Mild organophosphate exposure results in:
Moderate organophosphate exposure results in:
Organophosphate poisoning can lead to several significant consequences. These are some examples:
1.
According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.
2.
Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness
3.
Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer
4.
According to a study, taking part in a clinical trial for cancer may not actually increase survival.
5.
A new blood test greatly increases the ability to detect cancer.
1.
Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis
2.
Unraveling the Mysteries of Hematocrit: How It Impacts Your Health
3.
The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers
4.
Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer
5.
Surprising Symptoms of Prostate Cancer: What You Need to Know
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part X
2.
Efficient Management of First line ALK-rearranged NSCLC - Part III
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation